Company Updates
4Dx Featured on SBS World News
3rd March 2016, SBS News Andreas Fouras, Executive Chairman of 4Dx, provided insight into 4Dx’s potential for the life changing advancement of lung diagnostics and the huge opportunity for the commercialisation and export of IP from Australia’s leading universities. Andreas is supported by commentary from; Professor Ian Smith, Vice-Provost from Monash University and Associate Professor Louis Irving, the Director of […]
Recording of Crowd Mobile Investor Webinar and Teleconference Available
3rd March 2016, ASX Announcement Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) advises that a recording of the investor webinar and teleconference briefing held on Wednesday 2 March 2016 at 12.30pm (AEDT) regarding Crowd Mobile’s FY16 first half financial results has been made available on the Company’s website. The […]
Catcha Group March Update; iProperty Acquisition Complete & IFLIX Plans International Expansion
The past month marks a significant milestone in Catcha Group’s history. With REA’s acquisition of iProperty now complete, Catcha Group reflects on the company’s journey as a proud and nostalgic parent. With the “first child” having now left the Catcha nest, they are hugely excited about upcoming developments, as our their companies continue to grow rapidly and cement their market leadership throughout the region. iProperty’s story validates Southeast […]
Universal Biosensors Appoints David Hoey as Non-Executive Director
2nd March 2016, ASX Announcement Universal Biosensors, Inc. (ASX: UBI) today announced the appointment of Mr. David Hoey as an independent non-executive director to the Board of Universal Biosensors (UBI). This appointment forms part of the board renewal process which has occurred over recent years. Mr. Hoey has more than 25 years’ experience in technology […]
Prescient Featured on Bloomberg’s – The Redchip Money Report
2nd March 2016, ASX Announcement The new CEO of clinical-stage oncology company Prescient Therapeutics Ltd (ASX: PTX), Steven Yatomi-Clarke, will appear on Bloomberg Network’s The Red Chip Money Report later this week. Mr Yatomi-Clarke’s interview with host Dave Gentry will air on Sunday, March 6, at 3.30 p.m. HKT on Bloomberg Asia, and 5.30 p.m. […]
Christchurch Adventure Park into the Swing of Things
1st March 2016, NewsHub By Brooke Hobson Construction on the $20 million Christchurch Adventure Park is just two days away. The park is being developed on 358 hectares of forested land on the Cashmere Hills, between Dyers Pass, Worsleys and Summit roads. It includes the largest mountain bike park in the Southern Hemisphere and includes […]
OncoSil Market Update; Commercialisation, Clinical and Corporate Highlights
1st March 2016, ASX Announcement OncoSil Medical Limited (ASX: OSL) OncoSil Medical or the Company) provides the following update on its activities since the Quarterly Announcement on 28 January 2016. Commercialisation The Company continues to be in active engagement with the Notified Body for the CE Mark submission. By way of additional background on the […]
Analytica Half Year Report; Revenue Up 101%, R&D Costs Down
29th February 2016, Analytica Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System, today released its Appendix 4D – half year report for the six months ended 31st December 2015. Financial Results: Net loss down 37% to $1,216k Total revenue up 101% to $2,093k Direct research and development costs $1,259k down from $1,540k Market and […]
YPB Builds Strong Foundation for Accelerating Revenue Growth
29th February 2016, ASX Announcement Highlights: Development of the world’s first end to end anti-counterfeit and brand protection solution through YPB’s Protect, Detect and Connect model Revenue up to $1.7 million (FY 2014: $0.085 million), with strong Q4 EBITDA loss to $5.6 million (FY 2014: $4.2 million) as YPB invests in significant R&D and marketing […]
Backed By Leading Investment Groups and Family Offices
